Ozutemiz · Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 2002 · self-controlled before-after trial · n=14

Effect of omeprazole on plasma zinc levels after oral zinc administration.

Cited 16 times in the scientific literature.

Level 3 - non-randomized controlled study

Non-randomized, self-controlled before-and-after interventional trial in humans

PubMed 12546170 · record verified 2026-08-31

What was done

Fourteen healthy volunteers were evaluated before and after 7 days of oral omeprazole (60 mg/day). Fasting gastric pH, gastric volume, and basal and maximal acid outputs were measured. Plasma zinc levels were measured at baseline and at 1, 2, 3, and 4 hours after oral administration of 300 mg zinc sulfate to determine zinc absorption before and after omeprazole.

What was found

Omeprazole significantly increased fasting gastric pH from 2.4 to 5.5 (p < 0.001). Mean basal acid output decreased from 8.0 to 1.6 mEq/h (p < 0.001) and maximal acid output decreased from 106.6 to 20.6 mEq/h (p < 0.001). Zinc absorption decreased from 245 (35) mg/dL/h pre-omeprazole to 141 (34) mg/dL/h post-omeprazole (p < 0.01).

Why it matters

This study demonstrates that gastric acid suppression from proton pump inhibitors significantly reduces the intestinal absorption of orally administered zinc.

Limits

The study is limited by a very small sample size (n = 14) and an unblinded, non-randomized before-and-after design lacking a parallel control group. It tested a short duration (7 days) of high-dose omeprazole (60 mg/day) in healthy subjects, leaving chronic effects, clinical deficiency endpoints, and lower typical therapeutic doses unassessed.

Cited by